Starting today in Barcelona, Spain, the ESMO Congress 2019 aims to focus on novel approaches and breakthroughs that can drive advances along the three-stage course of cancer care, from laboratories to clinical settings and from clinical settings to the patient’s bedside. But how to translate research findings into improvements in cancer care? Commenting this year's tagline - "Translating science into better cancer care" - ESMO President Prof. Josep Tabernero, from Vall d'Hebron University Hospital, Barcelona, Spain, explains that cooperation among oncology stakeholders is key to ensure access to best options of care for patients.
Translating science into better cancer care
